From: Trends in respiratory diseases before and after the COVID-19 pandemic in China from 2010 to 2021
Disease | Phase 2 (2019) reported cases | Phase 1(2010–2018) | Phase 3 (2020) | Phase 4 (2021) | |||
---|---|---|---|---|---|---|---|
IRR (95%CI) | P-value | IRR (95%CI) | P-value | IRR (95%CI) | P-value | ||
Measles | 3573 | 4.69 (3.35–6.56) | < 0.001 | 0.35 (0.19–0.67) | 0.002 | 0.28 (0.14–0.57) | 0.001 |
Tuberculosis | 1,034,760 | 1.22 (1.16–1.28) | < 0.001 | 0.85 (0.79–0.91) | < 0.001 | 0.80 (0.75–0.85) | < 0.001 |
Pertussis | 30,727 | 0.21 (0.18–0.25) | < 0.001 | 0.20 (0.15–0.28) | < 0.001 | 0.36 (0.27–0.48) | < 0.001 |
Scarlet fever | 83,028 | 0.70 (0.61–0.81) | < 0.001 | 0.18 (0.13–0.25) | < 0.001 | 0.37 (0.29–0.47) | < 0.001 |
Seasonal influenza | 3,507,306 | 0.09 (0.07–0.12) | < 0.001 | 0.20 (0.13–0.33) | < 0.001 | 0.26 (0.16–0.40) | < 0.001 |
Mumps | 303,105 | 0.94 (0.88–1.01) | 0.121 | 0.44 (0.38–0.49) | < 0.001 | 0.41 (0.36–0.47) | < 0.001 |
Rubella | 34,151 | 0.56 (0.46–0.69) | < 0.001 | 0.08 (0.05–0.15) | < 0.001 | 0.06 (0.02–0.14) | < 0.001 |